These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31668943)

  • 21. Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma.
    Wang H; Hu Z; Sukumar UK; Bose RJ; Telichko A; Dahl JJ; Paulmurugan R
    Nanotheranostics; 2022; 6(1):62-78. PubMed ID: 34976581
    [No Abstract]   [Full Text] [Related]  

  • 22. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.
    Zhang J; Yang Y; Yang T; Yuan S; Wang R; Pan Z; Yang Y; Huang G; Gu F; Jiang B; Lin C; Zhou W
    Hepatology; 2015 Feb; 61(2):561-73. PubMed ID: 25251503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
    Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
    PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.
    Liu DL; Lu LL; Dong LL; Liu Y; Bian XY; Lian BF; Xie L; Wen D; Gao DM; Ke AW; Fan J; Wu WZ
    Theranostics; 2020; 10(8):3668-3683. PubMed ID: 32206115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.
    Roy S; Hooiveld GJ; Seehawer M; Caruso S; Heinzmann F; Schneider AT; Frank AK; Cardenas DV; Sonntag R; Luedde M; Trautwein C; Stein I; Pikarsky E; Loosen S; Tacke F; Ringelhan M; Avsaroglu SK; Goga A; Buendia MA; Vucur M; Heikenwalder M; Zucman-Rossi J; Zender L; Roderburg C; Luedde T
    Gastroenterology; 2018 Dec; 155(6):1951-1966.e26. PubMed ID: 30165047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
    Xue HY; Liu Y; Liao JZ; Lin JS; Li B; Yuan WG; Lee RJ; Li L; Xu CR; He XX
    Oncotarget; 2016 Dec; 7(52):86675-86686. PubMed ID: 27880727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
    Xu X; Zou H; Luo L; Wang X; Wang G
    FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
    Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
    Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes.
    Yan LJ; Guo XH; Wang WP; Hu YR; Duan SF; Liu Y; Sun Z; Huang SN; Li HL
    Curr Cancer Drug Targets; 2019; 19(4):330-337. PubMed ID: 30332960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
    Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
    Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
    Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.